Stock ENSG THE ENSIGN GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials The Ensign Group, Inc.

Equities

ENSG

US29358P1012

Healthcare Facilities & Services

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
117.2 USD -0.03% Intraday chart for The Ensign Group, Inc. -0.85% +4.49%
Apr. 18 Ensign Group Insider Sold Shares Worth $530,918, According to a Recent SEC Filing MT
Mar. 22 Ensign Group Keeps Quarterly Dividend at $0.06 Per Share, Payable by April 30 to Holders of Record on March 31 MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,421 3,912 4,593 5,203 6,283 6,672 - -
Enterprise Value (EV) 1 2,421 3,912 4,593 5,203 6,283 6,256 6,184 5,839
P/E ratio 23 x 23.8 x 24.5 x 24 x 30.7 x 22.5 x 20.3 x 18.3 x
Yield 0.42% - 0.25% 0.24% - - - -
Capitalization / Revenue 1.06 x 1.63 x 1.75 x 1.72 x 1.68 x 1.61 x 1.48 x 1.33 x
EV / Revenue 1.06 x 1.63 x 1.75 x 1.72 x 1.68 x 1.51 x 1.37 x 1.17 x
EV / EBITDA 10.4 x 13.4 x 13.6 x 13.6 x 15 x 13.1 x 11.7 x 9.93 x
EV / FCF 20.1 x - 22.3 x 28.1 x - 22.1 x 20.2 x 16.8 x
FCF Yield 4.99% - 4.49% 3.55% - 4.52% 4.96% 5.96%
Price to Book 3.71 x - 4.54 x 4.22 x - - - -
Nbr of stocks (in thousands) 53,353 53,648 54,705 54,998 55,994 56,905 - -
Reference price 2 45.37 72.92 83.96 94.61 112.2 117.2 117.2 117.2
Announcement Date 2/5/20 2/3/21 2/9/22 2/2/23 2/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,286 2,403 2,627 3,025 3,729 4,148 4,515 5,012
EBITDA 1 232.4 292.8 336.6 383.6 419.5 478.8 528 588.3
EBIT 1 144.6 238.2 280.6 321.2 347.1 392 436.1 481.8
Operating Margin 6.33% 9.91% 10.68% 10.62% 9.31% 9.45% 9.66% 9.61%
Earnings before Tax (EBT) 1 116.2 217.6 258 289.1 272.8 400.3 449.8 502.9
Net income 1 110.5 170.5 194.7 224.7 209.4 303.7 341 381.2
Net margin 4.84% 7.1% 7.41% 7.43% 5.61% 7.32% 7.55% 7.61%
EPS 2 1.970 3.060 3.420 3.950 3.650 5.200 5.790 6.400
Free Cash Flow 1 120.7 - 206.1 185 - 282.5 306.5 348
FCF margin 5.28% - 7.85% 6.11% - 6.81% 6.79% 6.94%
FCF Conversion (EBITDA) 51.92% - 61.25% 48.22% - 59% 58.05% 59.16%
FCF Conversion (Net income) 109.18% - 105.9% 82.32% - 93.03% 89.89% 91.29%
Dividend per Share 0.1925 - 0.2125 0.2225 - - - -
Announcement Date 2/5/20 2/3/21 2/9/22 2/2/23 2/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 668.5 693.1 713.4 732.5 770 809.5 886.8 921.3 940.8 980.4 1,001 1,020 1,044 1,081 1,096
EBITDA 1 84.74 88.43 92.73 96.1 96.59 98.16 99.78 102.8 108 108.9 114.9 117.1 121.5 125.3 125.8
EBIT 1 70.81 73.83 78.05 81.24 80.65 81.28 82.67 85.2 89.6 89.64 93.72 95.6 99.67 103 101.3
Operating Margin 10.59% 10.65% 10.94% 11.09% 10.47% 10.04% 9.32% 9.25% 9.52% 9.14% 9.36% 9.37% 9.55% 9.53% 9.25%
Earnings before Tax (EBT) 1 64.86 66.02 66.23 72.96 72.46 77.45 78.38 81.05 82.04 31.28 93.68 95.97 100.7 110.1 105.9
Net income 1 47.28 48.74 50.34 57.69 56.18 60.47 59.85 63.99 63.86 21.69 70.81 72.84 76.3 83.53 80.12
Net margin 7.07% 7.03% 7.06% 7.88% 7.3% 7.47% 6.75% 6.95% 6.79% 2.21% 7.07% 7.14% 7.31% 7.73% 7.31%
EPS 2 0.8300 0.8600 0.8900 1.010 0.9900 1.060 1.050 1.120 1.110 0.3800 1.150 1.220 1.250 1.370 1.260
Dividend per Share 0.0525 0.0550 0.0550 0.0550 0.0550 0.0575 0.0575 - 0.0575 - - - - - -
Announcement Date 10/27/21 2/9/22 4/28/22 8/1/22 10/26/22 2/2/23 4/26/23 7/27/23 10/25/23 2/1/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - - - - - 416 488 833
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 121 - 206 185 - 283 307 348
ROE (net income / shareholders' equity) 17.6% 23.1% 21.2% 19.8% 15.3% 0.2% - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 12.20 - 18.50 22.40 - - - -
Cash Flow per Share 3.430 - 4.840 4.790 - - - -
Capex 1 71.5 - 69.6 87.5 - 106 112 112
Capex / Sales 3.13% - 2.65% 2.89% - 2.56% 2.48% 2.23%
Announcement Date 2/5/20 2/3/21 2/9/22 2/2/23 2/1/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for The Ensign Group, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
117.2 USD
Average target price
132.4 USD
Spread / Average Target
+12.92%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
ENCOMPASS HEALTH CORPORATION Stock Encompass Health Corporation
+23.61% 8.26B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+20.75% 7.2B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-5.01% 4.25B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. ENSG Stock
  4. Financials The Ensign Group, Inc.